Expertise in
3
conditions

Laura C. Gioia

Montreal, QC, CA 
Expertise in
3
conditions
Montreal, QC, CA 

Overview

Laura Gioia practices practicing medicine in Montreal, Canada.

Ms. Gioia is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Atrial Fibrillation, Hypertension, and Thrombectomy.

She is actively involved in clinical research, co-authoring 70 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Montreal, QC, Canada
Other Locations
Montreal, Canada
Ottawa, ON, Canada
Edmonton, AB, Canada
Waterloo, ON N2L3G1, Canada
Calgary, AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Completed
Publish Date: September 01, 2026
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Early Anticoagulation With Rivaroxaban Versus Standard of Care in Determining Safety at 365 Days in Symptomatic Cerebral Venous Thrombosis
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Early Anticoagulation With Rivaroxaban Versus Standard of Care in Determining Safety at 365 Days in Symptomatic Cerebral Venous Thrombosis
Enrollment Status: Completed
Publish Date: December 14, 2022
Intervention Type: Drug
Study Drug: Rivaroxaban
Study Phase: Phase 2
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Previous Intracerebral Hemorrhage Study
Enrollment Status: Completed
Publish Date: March 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

70 Total Publications

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.
Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.
Journal: Stroke
Published: August 06, 2026

Frequently Asked Questions about Laura C. Gioia

Is Laura C. Gioia a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Laura C. Gioia is classified as an Distinguished expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Laura C. Gioia participate in research or clinical trials?

Yes. Laura C. Gioia has published 70 articles and abstracts on conditions like Stroke. You can view a list of Laura C. Gioia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gioia's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile